Diakonos Oncology Reports Phase 1 DOC1021 Survival Data
Houston, USA | May 1, 2026 Diakonos Oncology has reported positive Phase 1 clinical data for its investigational DOC1021...
Phase 1
Advertisement
Laguna Gains FDA IND Clearance for LGNA-100 Therapy
SAN FRANCISCO, CALIFORNIA, April 29, 2026 Laguna Biotherapeutics has announced that the U.S. Food and Drug Administration (FDA) has...
Kestrel Therapeutics Doses First Patient in KRAS Trial
WATERTOWN, MASSACHUSETTS, April 28, 2026 Kestrel Therapeutics Inc. has announced a major clinical milestone with the first patient dosed...
Alltrna Launches First Human Trial for tRNA Therapy AP003
CAMBRIDGE, Mass., USA, March 31, 2026 Alltrna has received regulatory approval to initiate the first-in-human clinical trial of AP003,...
Advertisement
